December 5, 2024
TOPLINE: The use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for obesity treatment increased more than twofold between the last half of 2022 and the […]
December 5, 2024
TOPLINE: Based on the literature and stakeholder input, the authors have identified barriers to care for people with early-onset type 2 diabetes (EOT2D) and have proposed […]
December 5, 2024
TOPLINE: Prior authorization may cause treatment delays for patients, prompt physicians to choose less optimal treatments, cause patients to abandon treatments, and result in adverse events […]
December 5, 2024
TOPLINE: Consuming five or more servings per week of dark chocolate is associated with a lower risk for type 2 diabetes (T2D) compared with infrequent or […]
December 5, 2024
TOPLINE: Medicare Advantage plans are inappropriately denying radiation therapy services significantly more frequently than other health services, new data show. METHODOLOGY: Medicare Advantage plans are expected […]
December 5, 2024
TOPLINE: A 12-month period of histological inflammation is linked to a modestly increased risk for fracture in patients with inflammatory bowel disease (IBD), with the most […]
December 5, 2024
TOPLINE: Veterans receiving blood pressure (BP) medication as needed while hospitalized were at a 23% higher risk for acute kidney injury (AKI) and a 1.5-fold greater […]
December 5, 2024
TOPLINE: Thoracic endovascular aortic repair (TEVAR) effectively treats blunt traumatic aortic injury (BTAI), with acceptable long-term survival, low reintervention rates, and early diagnosis of manageable complications […]
December 4, 2024
TOPLINE: Atherosclerotic cardiovascular disease (ASCVD) risk is higher with cutaneous lupus erythematosus (CLE) or systemic lupus erythematosus (SLE) than with psoriasis. METHODOLOGY: A retrospective matched longitudinal […]